Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Microbiome

A gut microorganism turns the dial on sugar intake

A Bacteroides vulgatus metabolite, pantothenate, induces secretion of the hormones GLP1 in the gut and FGF21 in the liver, which act on the hypothalamus to reduce sugar intake.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Pantothenate is a key metabolite of B. vulgatus that modulates sugar preference through the gut–liver–brain axis.

References

  1. Ahmad, E., Lim, S., Lamptey, R., Webb, D. R. & Davies, M. J. Lancet 400, 1803–1820 (2022).

    Article  PubMed  Google Scholar 

  2. de Wouters d’Oplinter, A. et al. Gut Microbes 13, 1959242 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  3. de Wouters d’Oplinter, A. et al. Microbiome 11, 94 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Zhang, T. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-024-01902-8 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Jensen-Cody, S. O. et al. Cell Metab. 32, 273–286.e6 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hirasawa, A. et al. Nat. Med. 11, 90–94 (2005).

    Article  CAS  PubMed  Google Scholar 

  7. Liu, D. et al. Hepatology 74, 2154–2169 (2021).

    Article  CAS  PubMed  Google Scholar 

  8. Chen, Q. et al. Free Radic. Biol. Med. 224, 600–617 (2024).

    Article  CAS  PubMed  Google Scholar 

  9. Fan, S. et al. Cell Metab. 35, 2011–2027 (2023).

    Article  CAS  PubMed  Google Scholar 

  10. Agustí, A. et al. Mol. Neurobiol. 58, 4959–4979 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amandine Everard.

Ethics declarations

Competing interests

A.E. is an inventor on patent applications dealing with the use of Akkermansia muciniphila and its components in the treatment of metabolic disorders. A.E. is an inventor on patent applications dealing with gut microorganisms in food reward dysregulations. The other authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fayt, C., Morales-Puerto, N. & Everard, A. A gut microorganism turns the dial on sugar intake. Nat Microbiol 10, 270–271 (2025). https://doi.org/10.1038/s41564-024-01917-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41564-024-01917-1

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing